Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06588647 · ClinicalTrials.gov registry record · NA
Improving Participation After Stroke Self-Management-Rehabilitation
A NA study of Stroke, sponsored by University of Missouri-Columbia.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT06588647: Recruiting NA study of Stroke, sponsored by University of Missouri-Columbia.
NCT06588647 is a NA study of Stroke that is actively recruiting participants, run by University of Missouri-Columbia. The registered enrollment target is 100 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06588647, a NA study of Stroke, is actively recruiting participants, sponsored by University of Missouri-Columbia.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall goal of this proposed study is to evaluate the efficacy of a small-group, stroke-specific, self-management program delivered via telehealth to improve self-efficacy, activity performance, and quality of life in individuals with sub-acute stroke.
Primary Outcome
Self-report measure of activity performance. Minimum = 1, Maximum = 10. Higher scores mean better performance.
Conditions Studied
Interventions
- BEHAVIORAL Improving Participation after Stroke Self-Management Program (IPASS)
- BEHAVIORAL Chronic Disease Self-Management Program (CDSMP)
Study Locations (1)
Missouri
- University of Missouri - Columbia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-12-16 |
| Est. Completion | 2029-12-15 |
| Phase | NA |
What NCT06588647 shows while recruiting
NCT06588647 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 2 interventions - of which Improving Participation after Stroke Self-Management Program (IPASS) is the first listed.
NCT06588647 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT06588647 about?
NCT06588647 is a clinical study titled "Improving Participation After Stroke Self-Management-Rehabilitation". The overall goal of this proposed study is to evaluate the efficacy of a small-group, stroke-specific, self-management program delivered via telehealth to improve self-efficacy, activity performance, and quality of life in individuals with sub-acute stroke.
What is the current status of trial NCT06588647?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2024-12-16. Estimated completion is 2029-12-15.
What conditions does trial NCT06588647 study?
This clinical trial studies the following conditions: Stroke.
What interventions are being tested in trial NCT06588647?
The interventions under investigation include: Improving Participation after Stroke Self-Management Program (IPASS) (BEHAVIORAL), Chronic Disease Self-Management Program (CDSMP) (BEHAVIORAL).
Who is sponsoring clinical trial NCT06588647?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06588647 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06588647's enrollment target sits among peer trials
100 135th of 454 higher than 309 of 454 other Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Tracking a Tactile Signal Along the Nervous System
RECRUITING · NA
-
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
RECRUITING · NA
-
Strategy Training for Individuals With Unilateral Neglect
RECRUITING · NA
-
Weight Loss and ExeRcise
RECRUITING · NA
-
Safety and Feasibility of an ExoNET for Supination Assistance for Stroke Survivors
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI